Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 4, 2026, 10:40 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 169–192 of 246 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Bone Calcification Clear all

Conditions: Bone Resorption, Osteoporosis
Interventions: Whey protein supplement, Placebo; Dietary Supplement
Lead sponsor: Yale University; Other
Eligibility: 60 Years to 85 Years
Enrollment: 208 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2012
U.S. locations: 2
States / cities: Farmington, Connecticut • New Haven, Connecticut

Conditions: Spinal Cord Injury, Spinal Cord Injuries, Trauma, Nervous System, Wounds and Injury, Central Nervous System Diseases, Spinal Cord Diseases, Gonadal Disorders, Endocrine System Diseases, Hypogonadism, Genital Diseases, Male, Spinal Cord Trauma, Injuries, Spinal Cord, Walking, Difficulty, Gait Disorders, Neurologic, Locomotion Disorder, Neurologic, Wounds and Injuries, Nervous System Diseases, Testosterone Deficiency, Androgen Deficiency, Hormone Deficiency
Interventions: Testosterone Enanthate, Locomotor Training; Drug · Behavioral
Lead sponsor: North Florida Foundation for Research and Education; Other
Eligibility: 18 Years and older · Male only
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 2
States / cities: Gainesville, Florida • Jacksonville, Florida

Conditions: Osteopenia
Interventions: Calcium Carbonate, Vitamin D3, Risedronate, Bone-loading exercises; Drug · Behavioral
Lead sponsor: University of Nebraska; Other
Eligibility: 19 Years and older · Female only
Enrollment: 276 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Uterine Fibroid, Endometriosis
Interventions: Not listed
Lead sponsor: Myovant Sciences GmbH; Industry
Eligibility: 18 Years to 50 Years · Female only
Enrollment: 660 participants
Timeline: 2018 – 2020
U.S. locations: 37
States / cities: Mobile, Alabama • Mesa, Arizona • Huntington Beach, California + 31 more

Conditions: Kaposi Sarcoma, KSHV Associated Multicentric Castleman Disease, Primary Effusion Lymphoma, IL-6 Related KSHV Associated Cytokine Syndrome
Interventions: Not listed
Lead sponsor: National Cancer Institute (NCI); NIH
Eligibility: 18 Years to 99 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Diabetes Mellitus, Type 2
Interventions: Rosiglitazone, Metformin; Drug
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 55 Years to 80 Years · Female only
Enrollment: 226 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 21
States / cities: Tucson, Arizona • Huntington Park, California • Los Angeles, California + 15 more

Conditions: Sinus Floor Augmentation, Maxillary Sinus
Interventions: Calcium phosphosilicate alloplastic bone putty in direct sinus augmentation, Anorganic bovine bone mineral in direct sinus augmentation; Procedure
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 75 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2019
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Breast Neoplasms
Interventions: Vitamin D, Calcium carbonate, Vitamin D, Placebo; Dietary Supplement · Drug · Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years and older · Female only
Enrollment: 63 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2009
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Regional Osteoporosis as a Result of Chemotherapy
Interventions: DXA Scan; Radiation
Lead sponsor: State University of New York - Upstate Medical University; Other
Eligibility: 16 Years to 40 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2006
U.S. locations: 1
States / cities: Syracuse, New York

Conditions: Hyperparathyroidism, Secondary
Interventions: Etelcalcetide, Placebo; Drug
Lead sponsor: Amgen; Industry
Eligibility: 18 Years to 100 Years
Enrollment: 515 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 45
States / cities: Mobile, Alabama • Azusa, California • Beverly Hills, California + 42 more

Conditions: Osteoporosis
Interventions: Soy protein; Dietary Supplement
Lead sponsor: Creighton University; Other
Eligibility: 55 Years to 72 Years · Female only
Enrollment: 203 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2001 – 2004
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Barrett's Esophagus, Erosive Esophagitis, Gastroesophageal Reflux Disease(GERD)
Interventions: Not listed
Lead sponsor: University of Pennsylvania; Other
Eligibility: 40 Years to 75 Years
Enrollment: 106 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Renal Osteodystrophy
Interventions: Low magnitude mechanical stimuli; Device
Lead sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); NIH
Eligibility: 21 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Osteoporosis, Hypomagnesemia
Interventions: EffCaMgCit, Placebo; Drug · Other
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 21 Years to 99 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 2
States / cities: Dallas, Texas

Conditions: Osteopenia
Interventions: AlgaeCal-1, AlgaeCal-2; Dietary Supplement
Lead sponsor: Integrative Health Technologies, Inc.; Network
Eligibility: 18 Years and older
Enrollment: 354 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2010
U.S. locations: 1
States / cities: San Antonio, Texas

Conditions: Joint Disease
Interventions: total hip arthroplasty implant; Device
Lead sponsor: MicroPort Orthopedics Inc.; Industry
Eligibility: 21 Years to 80 Years
Enrollment: 25 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Spokane, Washington

Conditions: Osteoporosis
Interventions: BONISTEIN(R) bone blend, Placebo; Dietary Supplement
Lead sponsor: dsm-firmenich Switzerland AG; Industry
Eligibility: 45 Years to 55 Years · Female only
Enrollment: 70 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2009
U.S. locations: 1
States / cities: Omaha, Nebraska

Conditions: Osteoporosis
Interventions: Soy Isolate, Control protein, Novasoy isoflavones, Placebo tablets; Dietary Supplement
Lead sponsor: United States Department of Agriculture (USDA); Federal
Eligibility: 65 Years and older · Female only
Enrollment: 97 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2001 – 2005
U.S. locations: 1
States / cities: Farmington, Connecticut

Conditions: Werner Syndrome
Interventions: Progerinin; Drug
Lead sponsor: PRG Science & Technology Co., Ltd.; Industry
Eligibility: 18 Years and older
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Osteoporosis, Hypercalcemia of Malignancy, Hyperparathyroidism, Bone Diseases, Endocrine
Interventions: Parathyroid Hormone-related Protein (1-36), parathyroid hormone (1-34), PTH (1-34) and PTHrP (1-36); Drug
Lead sponsor: University of Pittsburgh; Other
Eligibility: 24 Years to 35 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2017
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Osteoporosis, Vascular Calcification, Inflammation
Interventions: Vitamin K; Drug
Lead sponsor: National Institute on Aging (NIA); NIH
Eligibility: 60 Years to 80 Years
Enrollment: 452 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2001 – 2006
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Leukemia, Lymphoblastic, Acute, Osteoporosis
Interventions: Calcium carbonate (Tums), vitamin D, Placebo; Drug · Other
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: Not listed
Enrollment: 429 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2011
U.S. locations: 3
States / cities: Memphis, Tennessee

Conditions: Bone Mineral Density, Bone Strength
Interventions: LMHF mechanical stimulation active device, LMHF mechanical stimulation placebo device; Device
Lead sponsor: St. Jude Children's Research Hospital; Other
Eligibility: 7 Years to 17 Years
Enrollment: 81 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Memphis, Tennessee

Conditions: HIV Infection
Interventions: Alendronate, Placebo, Calcium carbonate/vitamin D; Drug · Dietary Supplement
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 11 Years to 24 Years
Enrollment: 52 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2017
U.S. locations: 7
States / cities: Los Angeles, California • Miami, Florida • Tampa, Florida + 4 more

Search by objective public record fields.

The Effect of Protein Supplementation on Bone Health in Healthy Older Men and Women

Locomotor Training With Testosterone to Promote Bone and Muscle Health After Spinal Cord Injury

Heartland Osteoporosis Prevention Study

Bone Mineral Density in Women With Uterine Fibroids or Endometriosis

Assessment of Bone Mineral Density in People Living With HIV and KSHV Associated Malignancies: A Retrospective Longitudinal Analysis

Study In Postmenopausal Women With Type 2 Diabetes Looking At Approved Diabetes Drugs And How They Affect Bone Health

Prospective Evaluation of Anorganic Bovine Bone Mineral Versus Calcium Phosphosilicate Alloplastic Bone Putty in Direct Sinus Augmentation: a Spilt-mouth Study

High Dose Vit D Musculoskeletal Symptoms & Bone Density in Anastrozole-Treated Breast Cancer With Marginal Vit D Status

Bone Mineral Density in Adult Survivors of Solid Pediatric Cancers

Efficacy and Safety of Etelcalcetide (AMG 416) in the Treatment of Secondary Hyperparathyroidism (SHPT) in Patients With Chronic Kidney Disease (CKD) on Hemodialysis

Effect of Soy Isoflavones on Bone Mineral Density and Physical Performance Indices

To Learn How Bone Structure and Bone Mass Change After Long-term PPI Use

Low Magnitude Mechanical Stimuli Effects on Bone Structure in ESRD

EffCaMgCit to Prevent Mineral Metabolism and Renal Complications of Chronic PPI Therapy

A Comparison of Changes in Bone Density With the Same Bone-health Plan, But With Different Bone-health Supplements

Evaluation of Bone Mineral Density Changes After Total Hip Replacement: A Two-Year Clinical and DXA Analysis

Investigation of the Effect of BONISTEIN(R) Bone Blend on Bone Mineral Density/Content and Biomarkers of Bone Health

Soy and Isoflavones Effect on Bone

Phase 2, Open-Label Study to Evaluate the Safety and Tolerability of Progerinin in Werner Syndrome

One Week Comparison Study of PTH and PTHrP Infusions

Effect of Vitamin K on Age-Related Bone Loss and Vascular Calcification

A Severity-Adapted Clinical Trial of Diminished Bone Mineral Density in Acute Lymphoblastic Leukemia Survivors

Vibration Intervention For Bone Enhancement In Childhood Cancer Survivors

Safety and Effectiveness of Alendronate for Bone Mineral Density in HIV-infected Children and Adolescents